CrazyRon, you are anything but crazy. Yes, if Leronlimab proves to be the SOC for moderate to severely COVID19 patients, the demand will create massive production, distribution, and other logistical challenges. IMO these challenges will require the support of the President's task force, DPA, FEMA, and international partners to succeed in the fastest possible timeframe.